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Smallest near-infrared ﬂuorescent protein evolved
from cyanobacteriochrome as versatile tag for
spectral multiplexing
Olena S. Oliinyk1, Anton A. Shemetov2, Sergei Pletnev3, Daria M. Shcherbakova2 & Vladislav V. Verkhusha1,2
From a single domain of cyanobacteriochrome (CBCR) we developed a near-infrared (NIR)
ﬂuorescent protein (FP), termed miRFP670nano, with excitation at 645 nm and emission at
670 nm. This is the ﬁrst CBCR-derived NIR FP evolved to efﬁciently bind endogenous bili-
verdin chromophore and brightly ﬂuoresce in mammalian cells. miRFP670nano is a monomer
with molecular weight of 17 kDa that is 2-fold smaller than bacterial phytochrome (BphP)-
based NIR FPs and 1.6-fold smaller than GFP-like FPs. Crystal structure of the CBCR-based
NIR FP with biliverdin reveals a molecular basis of its spectral and biochemical properties.
Unlike BphP-derived NIR FPs, miRFP670nano is highly stable to denaturation and degradation
and can be used as an internal protein tag. miRFP670nano is an effective FRET donor for red-
shifted NIR FPs, enabling engineering NIR FRET biosensors spectrally compatible with GFP-
like FPs and blue–green optogenetic tools. miRFP670nano unlocks a new source of diverse
CBCR templates for NIR FPs.
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Light absorption and ﬂuorescence of green ﬂuorescent protein(GFP)-like ﬂuorescent proteins (FPs) are limited to a visiblerange of optical spectrum. Therefore, near-infrared (NIR)
FPs and NIR biosensors are in high demand not only for deep-
tissue in vivo imaging1 but, even more importantly, for spectral
multiplexing with biosensors based on GFP-like FPs and com-
mon optogenetic tools based on opsins, LOV and CRY domains
that are activatable with blue-green light2.
Bacterial photoreceptors have absorbance spectra in the NIR
range due to covalently attached heme-derived linear tetrapyrrole
compounds and allow engineering NIR FPs1. Several photo-
receptors from a class of bacterial phytochrome photoreceptors
(BphPs) were developed into bright monomeric NIR FPs, which
efﬁciently bind endogenous biliverdin (BV) tetrapyrrole in
mammalian cells3–5. However, the BphP-derived NIR FPs mini-
mally require two domains, a PAS and a GAF, to covalently
attach a BV chromophore and also possess a complex “ﬁgure-of-
eight knot” structure topologically linking the GAF and PAS
domains, which affects their folding1. Another class of bacterial
photoreceptors, allophycocyanins (APCs), was also used to
engineer NIR FPs, such as smURFP from TeAPC and several
BDFPs from ApcF. Although the APC-based NIR FPs are smaller,
they have low efﬁciency of BV binding, resulting in signiﬁcantly
lower brightness in mammalian cells than the BphP-derived NIR
FPs6–8.
To overcome the drawbacks of the BphP- and APC-based NIR
FPs, we turned our attention to a class of cyanobacteriochrome
(CBCR) photoreceptors found in cyanobacteria9. Typical CBCRs
consist of one or more GAF domains and effector domains1,9.
GAF domains of CBCRs have several unique properties to con-
sider them for engineering of NIR FPs. First, a single CBCR GAF
domain is sufﬁcient for autocatalytic binding of tetrapyrrole
chromophore10, potentially allowing to engineer single-domain
FPs, twice smaller than the BphP-derived FPs. This binding
occurs via a conserved Cys residue located in the GAF domain, in
contrast to the Cys in the PAS domain in BphPs. Second, GAF
domains of CBCRs are naturally monomeric11,12, unlike typically
dimeric BphPs and oligomeric APCs1. Third, in contrast to
BphPs and APCs, various CBCR subclasses exhibit a large spec-
tral diversity and, moreover, a variety of photocycles in which
GAF domains reversibly photoconvert between ultraviolet (UV)/
blue-, blue/green-, green/red-, and red/NIR-absorbing forms13,14.
Fourth, CBCR GAF domains are also found as components of
complex signaling proteins15, suggesting that their structural fold
is naturally optimized to use in fusion constructs14.
Despite these advantages, CBCRs utilize phycocyanobilin
(PCB) tetrapyrrole as a chromophore. PCB is naturally present in
plant and cyanobacteria but not in mammalian cells, which
produce BV3,16,17. Recently, however, three CBCR GAF domains
from Acaryochloris marina were shown to bind both PCB and
BV18–20. Moreover, GAF domains in the BphP-derived NIR FPs
were adopted to covalently bind BV21,22. Based on these ﬁndings,
we hypothesized that CBCRs can be engineered into BV-binding
NIR FPs.
Here, we expressed various CBCRs in BV-producing Escher-
ichia coli bacteria and found that the GAF domain of NpR3784
CBCR23 weakly binds BV and can be a template for NIR FP
engineering. We next subject NpR3784 GAF to multiple rounds
of molecular evolution, which resulted in the ﬁrst CBCR-derived
NIR FP. Importantly, similar to the BphP-based FPs, the CBCR-
derived NIR FP brightly ﬂuoresces in mammalian cells without
supplementation of exogenous BV chromophore. Characteriza-
tion of the developed NIR FP showed its numerous advantages
over NIR FPs developed from other photoreceptors, including
monomeric state, substantially smaller size, signiﬁcantly higher
protein stability in vitro and in mammalian cells, and possibility
to be inserted inside of tagged proteins. Spectral properties of the
CBCR-derived NIR FP enable its application as an efﬁcient
ﬂuorescence resonance energy transfer (FRET) donor for a red-
shifted BphP-derived NIR FP acceptor and engineering of fully-
NIR kinase biosensors. Cross-talk-free use of the NIR biosensors
with blue-light-activatable optogenetic kinase inhibitors in the
same cells demonstrates the applicability of the CBCR-based NIR
FP in all-optical techniques.
Results
Engineering of the CBCR GAF domain into BV-binding FP.
To choose a template for engineering of BV-binding CBCR-based
NIR FP, we evaluated GAF domains from ten different CBCRs
(Supplementary Fig. 1a). To facilitate protein production in
mammalian cells, we ﬁrst codon-optimized the CBCR genes for
mammalian cell expression. To facilitate BV binding, we then
introduced Leu residues at the position corresponding to Leu337
in AM1_1557g2, which was shown being important for the BV
attachment18,20. To reduce size of the CBCR GAF domains, we
next removed the N-terminal α1-helix, which does not participate
in the formation of the tetrapyrrole-binding pocket24.
These CBCRs were co-expressed in E. coli with heme
oxygenase for BV production; however, they exhibited very weak
or no ﬂuorescence. Interestingly, an NpR3784 GAF domain
substantially outperformed the GAF domains of other CBCRs,
including AM1_1557g2 and AM1_1870g3 that earlier were
shown to bind BV (Supplementary Fig. 1b, c). We subjected the
NpR3784 GAF domain to several rounds of random mutagenesis,
followed by saturating mutagenesis of the identiﬁed residues
(Supplementary Fig. 2). After each round, we tested the best
clones in mammalian cells and selected for the next molecular
evolution only those which exhibited the high ﬂuorescence
brightness in both bacteria and mammalian cells (Fig. 1). Totally,
17 rounds of the directed molecular evolution resulted in an NIR
FP variant, termed miRFP670nano, consisting of 147 amino acid
residues (17 kDa) and bearing 18 substitutions (numbering
follows that for miRFP670nano sequence) relative to wild-type
GAF from NpR3784: V7M, F25C, M26V, Y27F, P31E, S41A,
A48S, N51K, Q55R, T57R, I72Y, G82N, H87Y, N99I, N117H,
C119L, L136Q, and Q139V (Supplementary Fig. 2).
Characterization of miRFP670nano protein in vitro.
miRFP670nano exhibited ﬂuorescence excitation and emission
maxima at 645 and 670 nm, respectively, which were close to
those observed for blue-shifted two-domain BphP-based NIR
FPs, like miRFP670 (Fig. 2a and Table 1). Absorbance of
miRFP670nano had a minor peak at 390 nm corresponding to the
Soret band, characteristic for tetrapyrrole-binding proteins, and a
major peak at 645 nm, suggestive of the efﬁcient BV incorpora-
tion (Supplementary Fig. 3a). miRFP670nano exhibited mono-
meric behavior in size-exclusion chromatography at high
concentration of 10 mgml−1 (Fig. 2b and Supplementary Fig. 3b).
Notably, with ﬂuorescence quantum yield of 10.8% and extinction
coefﬁcient of 95,000M−1 cm−1, molecular brightness (a product
of molar extinction coefﬁcient and quantum yield) of
miRFP670nano exceeded that of the most of BphP-based NIR
FPs (Table 1).
miRFP670nano had substantially higher protein stability than
BphP-based NIR FPs. Studies of a pH dependence revealed that
miRFP670nano ﬂuorescence is stable between pH 4.0 and 8.0,
with pKa= 3.7, which was notably acid-shifted than for BphP-
derived NIR FPs, having pKa= 4.5 (Fig. 2c and Table 1).
Moreover, after 24 h incubation in 3.0 M guanidine hydrochloride
miRFP670nano retained ~80% of its ﬂuorescence, whereas
miRFP670 and miRFP703 were stable up to 1.5 M guanidine
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-018-08050-8
2 NATURE COMMUNICATIONS |          (2019) 10:279 | https://doi.org/10.1038/s41467-018-08050-8 | www.nature.com/naturecommunications
hydrochloride concentration only (Supplementary Fig. 4). Likely,
the compact and tight structure enhanced the miRFP670nano
resistance to denaturating conditions.
miRFP670nano maturation had a half-time of ~100 min
(Fig. 2d), which was 1.8-fold faster than for spectrally similar
two-domain miRFP670, suggesting that the single-domain
structure and the absence of the characteristic for all BphP-
based NIR FPs ﬁgure-of-eight knot structure accelerated the
miRFP670nano folding.
Performance of miRFP670nano in mammalian cells.
miRFP670nano efﬁciently binds endogenous BV in mammalian
cells. The cellular (a.k.a. effective) brightness of miRFP670nano
was comparable to that to miRFP670 and exceeded that of
miRFP703 in all tested mammalian cells (Fig. 2e). The high
effective brightness in the absence of exogenous BV in mam-
malian cells is an essential advantage of BphP-based NIR FPs over
APC-derived FPs (Table 1)3,7,8,16,17. While BV is the major
chromophore for BphPs, it is not the case for CBCRs for which
PCB is the primary tetrapyrrole co-factor, emphasizing the efﬁ-
ciency of the applied molecular evolution resulted in
miRFP670nano.
In mammalian cells miRFP670nano exhibited 2.8- and 1.3-fold
higher photostability than miRFP670 and miRFP703, respectively
(Fig. 2f, Table 1). miRFP670nano also exhibited low cytotoxicity
(Supplementary Fig. 5). The high photostability, low cytotoxicity,
and high effective brightness make miRFP670nano a favorable
NIR FP for imaging of long-term cellular events.
miRFP670nano is highly stable in mammalian cells. Protein
degradation analysis showed that after 4 h incubation with a
protein synthesis inhibitor cycloheximide miRFP670nano-
expressing cells retained ~95% of their ﬂuorescence (Fig. 2g).
Similar cellular stability was observed for enhanced green
ﬂuorescent protein (EGFP). In contrast, cells expressing
miRFP670 or miRFP703 retained only ~70 and 60% of
ﬂuorescence, respectively. Furthermore, incubation with borte-
zomib, an inhibitor of proteasome-dependent protein degrada-
tion, just slightly increased brightness of the miRFP670nano-
and EGFP-expressing cells (16 and 11%, respectively) (Fig. 2h).
On the contrary, the cellular brightness of BphP-based FPs was
increased more than 40% after inhibition of proteosomal
degradation. Moreover, a comparison of the number of
ﬂuorescent cells 48 and 120 h after transfection for all these
FPs conﬁrmed the high miRFP670nano cellular stability
(Supplementary Fig. 6). While overall number of miRFP670-
and miRFP703-expressing cells decreased more than twice 120 h
after transfection, the number of miRFP670nano-expressing cells
decreased ~10% only, which was similar to those with EGFP.
Live-cell imaging allows monitoring of dynamic events, but
some studies require cell ﬁxation. We compared tolerance of
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Fig. 1 Molecular engineering of miRFP670nano. a–n Comparison of clones selected on each round of selection in HeLa cells. The main mutations are
indicated. o Quantiﬁcation of the data represented in a–n. Mean NIR ﬂuorescence intensity was normalized to mean green ﬂuorescence intensity of
co-expressed EGFP and to mean ﬂuorescence intensity of mock-transfected cells. Error bars, s.d. (n= 3; transfection experiments)
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miRFP670nano and BphP-based miRFP670 and miRFP703 to
ﬁxation with 4% paraformaldehyde. Again, the miRFP670nano-
transfected cells demonstrated the highest stability and retained
more than 80% of ﬂuorescence after 30 min ﬁxation (Fig. 2i).
Overall, likely due to the compact and robust protein fold
CBCR-derived miRFP670nano exhibits the high cellular bright-
ness and signiﬁcantly enhanced protein stability in vitro and in
mammalian cells.
Structural basis of miRFP670nano properties. To reveal the
structural basis of the protein stability, brightness, and speci-
ﬁcity to BV chromophore, we determined the crystal structure
of miRFP670nano at 1.95 Å resolution (Fig. 3 and Supple-
mentary Fig. 7). miRFP670nano adopts a GAF-domain fold, but
with the N and C termini located in the spatial proximity
(Fig. 3a and Supplementary Fig. 7a). The GAF domain of BphPs
has the similar fold; however, it is topologically linked to the
adjacent PAS domain via a loop in the ﬁgure-of-eight knot
(Fig. 3b). The closest available structure of the GAF domain of
CBCR is a structure of putative phototaxis regulator PixJ of
Anabaena sp. PCC 7120, AnPixJ, in the red-absorbing state24
(Fig. 3c).
BV is covalently attached by a thioether bond between the
conserved for CBCRs Cys86 residue and the C31 atom of the
ring A (Fig. 3d, h and Supplementary Fig. 7b), similar to the
native CBCR’s PCB chromophore (Fig. 3g, m), but having a
double bond between C31= C32. This mode of the BV binding
is different than in natural BphPs and red-shifted BphP-
derived NIR FPs in which BV is attached via the C32 atom of
the ring A to a conserved Cys in the PAS domain. Recently,
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Fig. 2 Characterization of miRFP670nano. a Fluorescence excitation and emission spectra of miRFP670nano. b Size-exclusion chromatography of
miRFP670nano at concentration 10mgml−1 and indicated molecular weight standards. miRFP670nano with polyhistidine tag and linker runs as a monomer
with the apparent molecular weight of 18.8 kDa. c pH dependencies of NIR ﬂuorescence for miRFP670nano and miRFP670. d Kinetics of miRFP670nano and
miRFP670 maturation. Time “0” corresponds to the beginning of the 1-h-long pulse-chase induction of the protein expression in bacteria. e Effective
(cellular) brightness of miRFP670nano, miRFP703, and miRFP670 in mammalian cells. Live HeLa, U87, U-2 OS, PC6-3, and NIH3T3 cells were transiently
transfected with miRFP670nano, miRFP703, or miRFP670. Fluorescence was analyzed by ﬂow cytometry 72 h after transfection. NIR ﬂuorescence intensity
was normalized to that of co-transfected EGFP (to account for differences in transfection efﬁciency), to excitation efﬁciency of each NIR FP by 640 nm laser,
and to emission spectrum of each FP in the emission ﬁlter. Effective brightness of miRFP670 was assumed to 100% for each cell line. Error bars, s.d. (n= 3;
transfection experiments). f Photobleaching of miRFP670nano and miRFP670 in live HeLa cells. g Mean ﬂuorescence intensity of HeLa cells transiently
transfected with miRFP670nano, miRFP703, miRFP670, and EGFP before and after 4 h of incubation with 20 µgml−1 cycloheximide. Error bars, s.d. (n= 5;
transfection experiments). h Mean ﬂuorescence intensity of HeLa cells transiently transfected with miRFP670nano, miRFP703, miRFP670, and EGFP before
and after 4 h of incubation with 10 µM bortezomib. Error bars, s.d. (n= 5; transfection experiments). i Tolerance of miRFP670nano to ﬁxation in
paraformaldehyde. HeLa cells transfected with miRFP670nano, miRFP670, and miRFP703 were incubated with 4% paraformaldehyde for 10–60min. The
ﬂuorescence of cells treated with paraformaldehyde was normalized to ﬂuorescence of non-ﬁxed cells. Error bars, s.d. (n= 3; transfection experiments)
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bound to Cys residues in d miRFP670nano, e miRFP670, f BphP1-FP, and g AnPixJ. Carbon, nitrogen, oxygen, and sulfur atoms are in white, blue, red, and
yellow, respectively. Single chromophore species are observed in miRFP670nano and AnPixJ only. Two BV chromophore species are observed in
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the GAF domain, and the BV chromophore (j) is bound via the C31 atom to Cys253 in the GAF domain and also via the C32 atom to Cys20 in the PAS
domain. In BphP1-FP the BV chromophore (k) is bound via the C31 atom to Cys253 in the GAF domain, and the BV chromophore (l) is bound via the C32
atom to Cys253 residue in the GAF domain. In AnPixJ the PCB chromophore (m) is bound to the Cys201 residues via the C31 atom
Table 1 Properties of currently available monomeric NIR FPs designed from various bacterial photoreceptors
NIR FP Parental bacterial
photoreceptor
Ex
(nm)
Em
(nm)
Extinction
coefﬁcient
(M−1cm−1)
Quantum
yield (%)
Molecular
brightness vs.
miRFP670 (%)
Oligomeric
state
pKa Photostability
in HeLa cells,
t1/2 (s)
Brightness in
mammalian cells
vs miRFP670 (%)a
Ref.
miRFP670
nano
NpR3784
cyanobacteriochrome
645 670 95,000 10.8 84 Monomer 3.7 505 100b This
work
miRFP670 RpBphP1 bacterial
phytochrome
642 670 87,400 14.0 100 Monomer 4.5 183 100 3
miRFP703 674 703 90,900 8.6 64 Monomer 4.5 394 61
miRFP709 683 709 78,400 5.4 35 Monomer 4.5 192 42
miRFP720 RpBphP2 bacterial
phytochrome
702 720 98,000 6.1 49 Monomer 4.5 510 160 5
mIFP BrBphP bacterial
phytochrome
683 704 82,000 8.4 56 Monomer 4.5 54 26 4,8
smURFP TeAPCα
allophycocyanin
642 670 180,000c 18.0 265c Dimer – 570 1 6,8
BDFP1.5 ApcF allophycocyanin 688 711 74,000 5.0 30 Monomer 2.0 1310d 0.5d 7
aUnless otherwise stated, it is determined as effective NIR ﬂuorescence in live HeLa cells 72 h after transfection with no supply of exogenous BV and after normalization to ﬂuorescence of co-transfected
EGFP
bEffective brightness of miRFP670nano in various mammalian cell lines is compared in Fig. 2e
cDetermined for a dimer of smURFP molecules
dBased on the comparison with smURFP in HEK293 cells in ref. 7
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however, the unusual covalent binding of BV to Cys in the GAF
domain was described for blue-shifted NIR FPs, such as
miRFP670 and BphP1-FP, containing the engineered Cys
residue in the GAF domain21,22,25. While only one BV
chromophore type is detected in the crystal structure of
miRFP670nano (Fig. 3d), the blue-shifted BphP-based NIR FPs
have two different chromophore types21,22 (Fig. 3e, f), resulting
in two distinct protein species present in miRFP670, as well as
in BphP1-FP. miRFP670nano chromophore has the same
number of conjugated double bonds as the chromophores in
blue-shifted BphP-based NIR FPs (Fig. 3h–l) that explains the
similarity of spectra for these three NIR FPs21.
Immediate chromophore environment is critical for BV
binding and ﬂuorescence of miRFP670nano. In the
chromophore-binding pocket, BV is stabilized by eight hydrogen
bonds with D56, Y67, T84, R71, and H117, π–π stacking with
Y87, and T-stacking with F59 (Supplementary Fig. 7c, d). A
pyrrole water, a proton donor providing excited-state proton
transfer in BphP-derived NIR FPs and natural BphPs, is absent in
miRFP670nano, similar to CBCR AnPixJ24. Its role is likely
played by the side chain of D56, which forms H-bonds with
pyrrole nitrogens of the rings A, B, and C24.
Of the 18 amino acid substitutions introduced into parental
NpR3784g (Supplementary Fig. 7e), F25C, Y27F, H87Y, N99I, and
N117H are located within 3.6 Å of the chromophore and either
directly stabilize it or provide for it favorable accommodation. One
of the important substitutions, N117H makes a strong H-bond
with the ring D, which is absent in NpR3784g, thus preventing
rotation of this ring and non-radiative energy dissipation via
photoswitching. Another critical mutation is H87Y, which
introduced a perfect parallel π–π stacking with BV. F25C makes
additional space in the chromophore-binding pocket, possibly
enhancing BV accommodation. T57R substitution introduced a
ﬂexible positively charged residue near the chromophore binding
site, enabling electrostatic attraction of BV and its additional
shielding from solvent. Substitutions Y27F and N99I increased the
hydrophobicity of the chromophore environment.
Such a favorable chromophore binding pocket within a
compact single GAF domain fold should make miRFP670nano
a robust probe for various applications.
Performance of miRFP670nano as protein fusion tag. To test
performance of miRFP670nano as ﬂuorescent probe for labeling
of intracellular structures, we constructed several miRFP670nano
N- and C-terminal protein fusions. In live mammalian cells these
fusions exhibited proper localization, including the fusions asso-
ciated with or forming ﬁlaments (Fig. 4). miRFP670nano fusion
with histone 2B localized properly in different phases of mitosis
and did not affect cell division (Fig. 4k). Cell images showed
homogenous distribution of miRFP670nano and absence of
intracellular aggregates (Fig. 4l).
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Fig. 4 miRFP670nano fusions imaged using epiﬂuorescence microscopy. Live HeLa cells transfected with the miRFP670nano N- and C-terminal fusion
constructs. The C-terminal fusions are a actin; b vesicular protein clathrin; c myosin; d α-tubulin. The N-terminal fusions are e α-actinin; f microtubules-
binding EB3; g keratin; h actin-binding LifeAct; i lysosomal membrane glycoprotein LAMP1; j vimentin; k histone H2B. l Cells expressing untagged
miRFP670nano. m Dissociated rat cortical neurons transfected with miRFP670nano encoding plasmid at 3 days in vitro (DIV 3). Neurons were imaged 48
h after transfection. Left images are zoom-in of the indicated areas of the right images. n Two-color images of cells co-expressing α-tubulin tagged with
miRFP670nano and H2B tagged with miRFP720. o Two-color images of cells co-expressing LAMP1 tagged with miRFP720 and H2B tagged with
miRFP670nano. pmiRFP670nano internally inserted between the helical and GTPase domains of the G-protein α subunit (Gαs). rmiRFP670nano internally
inserted into the intracellular loop 3 of the β2 adrenergic receptor (β2AR). mVenus with membrane targeting CAAX motif was used for membrane
visualization. Scale bars, 10 μm
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In number of cases, placing of a FP tag at the termini of
proteins affects their function or leads to incorrect localization26.
Such proteins can be labeled with FP inserted in a middle of the
sequence as an internal tag. For this, FP should have good folding
properties and its N- and C-termini located close to each other,
like in miRFP670nano (Fig. 3a and Supplementary Fig. 7a).
To evaluate miRFP670nano as an internal tag, we constructed
internally labeled G protein α-subunit (Gαs) and β2-adrenergic
receptor (β2AR) in which miRFP670nano or miRFP670 were
inserted between the helical and GTPase domains of Gαs and into
intracellular loop 3 of β2AR27,28. Both miRFP670nano internal
fusions demonstrated perfect membrane localization, co-
localizing with mVenus containing a CAAX-motif for membrane
targeting. In contrast, the internal fusion constructs with two-
domain miRFP670 did not exhibit membrane localization and
formed aggregates (Fig. 4p, r and Supplementary Fig. 8a–d). Most
likely the complex structural organization of BphP-derived
miRFP670 interfered with folding of internally tagged Gαs and
β2AR. Notably, unlike BphPs, GAF domains of CBCRs are often
found as modular components of complex signaling proteins15,
suggesting that miRFP670nano has naturally optimized structure
for ﬂexible design of fusion constructs.
We next evaluated applicability of miRFP670nano for imaging
of primary cell cultures, such as neurons. Primary rat cortical
neurons transfected with miRFP670nano exhibited bright homo-
genous ﬂuorescence without supplying exogenous BV (Fig. 4m).
To evaluate miRFP670nano in two-color NIR imaging with
monomeric BphP-derived red-shifted miRFP7205, we imaged
HeLa cells co-expressing different miRFP670nano and miRFP720
fusions (Fig. 4n, o). All fusions had proper localization and clear
separation of miRFP670nano and miRFP720 ﬂuorescence signals.
Notably, endogenous BV concentration was sufﬁcient to provide
bright ﬂuorescence to both NIR FPs co-expressed in the same
cells.
NIR FRET biosensors of PKA and JNK kinases. The high
photostability, small size, and relatively high quantum yield make
miRFP670nano a promising FRET donor for red-shifted
miRFP7205. To evaluate this FRET pair, we fused miRFP670-
nano and miRFP720 via linker with a cleavage site for caspase-3,
the key protease in apoptosis (Supplementary Fig. 9a). Upon
apoptosis induced by staurosporine, we observed ~1.65-fold
decrease in the FRET/miRFP670nano ﬂuorescence ratio detected
at 725 nm/667 nm in HeLa cells transfected with the
miRFP670nano-miRFP720 caspase-3 reporter (Supplementary
Fig. 9b-e). These results suggested that miRFP670nano and
miRFP720 can be successfully used to design fully NIR FRET
biosensors.
We next constructed biosensors for detection of protein kinase A
(PKA) and c-Jun N-terminal kinase (JNK) activities29. PKA is one of
the key effectors of cAMP-mediated signaling pathway, while JNK
regulates cellular responses to diverse environmental stress signals
and inﬂammatory cytokines30. The NIR biosensors consisted of a
miRFP670nano donor, a phosphoamino acid-binding domain, a
consensus peptide sequence of kinases substrates, and a miRFP720
acceptor (Fig. 5a). Phosphorylation of the substrate peptide by
activated kinases leads to a conformation rearrangement of the
biosensor and an increase of FRET between donor and acceptor.
Stimulation of HeLa cells stably expressing NIR PKA biosensor
with 1 mM dibutyryl cyclic adenosine monophosphate (dbcAMP)
led to a fast increase in the FRET/miRFP670nano ﬂuorescence
ratio, which reached ~33% in 1 h. The response was not detected
in the presence of PKA inhibitor AT13148 (Fig. 5b, c). Treatment
of HeLa cells expressing the NIR JNK biosensor with 1 μg ml−1
anisomycin, a JNK agonist31, led to an increase of the FRET/
miRFP670nano ﬂuorescence ratio with typical for JNK kinetics32,
which reached ~35% in 1 h. Incubation with JNK inhibitor
SP600125 prevented the response to anisomycin (Fig. 5d, e). Both
NIR biosensors exhibited the high dynamic range, similar to that
for the PKA and JNK biosensors based on the ECFP-Venus and
ECFP-Citrine pairs32,33.
Spectral multiplexing of NIR biosensors. Important advantage
of fully NIR biosensors is their spectral compatibility with GFP-
like FPs and common optogenetic tools activatable with blue
light. We co-expressed NIR JNK biosensor and EGFP-based p38
kinase translocation reporter (p38 KTR)34 in HeLa cells. Similarly
to JNK, p38 kinase is activated by stress signals and inﬂammatory
cytokines30,31. After treatment of cells with anisomycin, which
induces activation of both kinases31, we observed response of
both biosensors, NIR JNK and p38 KTR (Fig. 6).
While the combination of several biosensors enables monitoring
of several cell processes, a combination of biosensors with
optogenetic tools should allow simultaneous detection and regula-
tion of the processes. This is a powerful all-optical approach to
study cell signaling in native environment. Recently, a blue-light-
controlled optogenetic JNK inhibitor (optoJNKi) and a photo-
activatable PKA inhibitor (PA-PKI), based on the LOV2 domain
from Avena sativa phototropin 1, were developed35,36. In these
optogenetic tools, PKA or JNK inhibitory peptides are fused to a Jα
helix of the LOV2 domain (Fig. 7a). In darkness, the peptides are
sterically blocked from kinase interaction, whereas blue light leads
to unfolding of the Jα helix, uncaging the peptides and,
consequently, to kinase inhibition35,36. Absorbance spectrum of
LOV2 domain and excitation spectra of miRFP670nano donor and
miRFP720 acceptor have minimal overlap (Supplementary Fig. 10).
To evaluate compatibility of optoJNKi and PA-PKI with NIR
biosensors, we transfected HeLa cells stably expressing JNK or
PKA biosensors with the respective optogenetic inhibitors. Cells
transfected with the optogenetic tools responded to stimuli
similarly to the cells expressing the biosensors
only (Supplementary Fig. 11 and 12). However, under blue light
cells with the optogenetic constructs exhibited the substantial
decrease in response to the stimuli (Fig. 7b–e). This demonstrated
that the NIR JNK and PKA biosensors can be efﬁciently spectrally
multiplexed with optogenetic tools in the same cells.
Characterization of miRFP670nano in vivo. To compare
miRFP670nano with miRFP670 in in vivo imaging, we injected
miRFP670nano- or miRFP670-expressing HeLa cells co-
transfected with RLuc8 luciferase in mammary glands of mice.
The miRFP670 and miRFP670nano ﬂuorescence signals were
normalized to Rluc8 bioluminescence to account for transfection
efﬁciency. We found that in vivo brightness of miRFP670nano
cells was comparable to that of miRFP670 cells (Fig. 8a, b). We
then estimated the minimal detectable quantity of cells expressing
miRFP670nano. For this, we injected in mammary glands various
amounts of transiently transfected cells and found that we were
able to detect ~1.5 × 105 ﬂuorescent cells (Fig. 8c, d). We next
tested miRFP670nano in two-color whole-body imaging. Cells
transfected with either miRFP670nano or miRFP720 were well
spectrally distinguished in mice using two channels with ex./em.
at 640 nm/680 nm and 675 nm/720 nm, respectively (Fig. 8e).
Overall, these in vivo results showed that miRFP670nano per-
forms well in whole-body imaging and can be used in combi-
nation with red-shifted NIR FPs.
Discussion
By applying 17 rounds of molecular evolution to the GAF domain
of PCB-binding NpR3784 CBCR, we have developed the ﬁrst
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CBCR-based NIR FP, which efﬁciently binds endogenous BV and
ﬂuoresces in various mammalian cells (Figs. 2e, 4). With mole-
cular weight of only 17 kDa, miRFP670nano is the smallest
monomeric NIR FP that ﬂuoresces in mammalian cells as bright
as twice bigger state-of-art two-domain NIR FPs.
We step-by-step compared miRFP670nano with two spectrally
closest monomeric BphP-based NIR FPs, miRFP670, and
miRFP703 (Table 1). The effective brightness of miRFP670nano
in cells is similar to that of miRFP670 and exceeds that of
miRFP703 (Fig. 2e). The only example of a single-domain BphP-
based FP, monomeric GAF-FP37, has more than 30-fold lower
cellular brightness, and all APC-derived FPs have more than 80-
fold lower cellular brightness than miRFP670nano6–8 (Table 1).
Comparing to BphP-based NIR FPs, miRFP670nano is char-
acterized by high stability to acidic environment, denaturation
conditions, cell ﬁxation, and degradation in mammalian cells
(Fig. 2c, g, h, i and Supplementary Fig. 4 and 6). Compact protein
fold with N and C termini in a close proximity allows the use of
miRFP670nano not only as a protein terminal tag but also as an
insertion inside the loops of a protein of interest, as demonstrated
for Gαs and β2AR (Fig. 4p, r and Supplementary Fig. 8). In
contrast, two-domain BphP-derived NIR FPs, which have the
ﬁgure-of-eight knot in their structure and distant termini, are not
suitable for internal tagging.
The crystal structure of miRFP670nano allows to visualize the
chromophore and its immediate environment optimized during
molecular evolution for BV binding and ﬂuorescence (Supple-
mentary Fig. 7). Bound to the conserved Cys86 via its C31 atom,
BV forms a chromophore, which lacks a double bond between C2
and C3, but has a double bond between C31 and C32. The
number of conjugated double bonds in this chromophore is the
same as in the chromophores of blue-shifted BphP-derived NIR
FPs that explains their spectral similarity (Fig. 3h–l). However,
the BphP-derived NIR FPs have two different chromophore types
(Fig. 3e, f), which leads to heterogeneity of the protein species
and, consequently, affects their properties. Likely, the presence of
two protein species in miRFP670 explains its slightly sigmoidal
maturation (Fig. 2d), bi-exponential photobleaching (Fig. 2f), and
wider spread of denaturation dependence (Supplementary Fig. 4).
The chromophore homogeneity is another important advantage
of CBCR-based miRFP670nano over blue-shifted BphP-based
NIR FPs.
Relatively high quantum yield of miRFP670nano and good
overlap of its emission with miRFP720 excitation make
miRFP670nano a favorable FRET donor for red-shifted NIR FPs.
That was demonstrated by the development of efﬁcient fully-NIR
biosensors of PKA and JNK activities (Fig. 5). JNK is key trans-
ducer of exogenous stress signals and is involved in regulation of
a number of physiological and pathological processes including
apoptosis, proliferation, embryonic development, and inﬂamma-
tion. PKA mediates signals of G protein-coupled receptors and
regulates a plethora of downstream effectors involved in key
cellular processes. The developed NIR PKA and JNK biosensors
enable multiplexing with blue-green optogenetic tools for probing
and monitoring of multiple cell processes for better under-
standing of mechanisms that mediate regulation and speciﬁcity of
PKA and JNK kinases. Simultaneous detection and light control
of the PKA and JNK activities using the fully-NIR
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Fig. 5 NIR biosensors for detection of PKA and JNK kinase activities. a Schematic representation of miRFP670nano-miRFP720-based NIR FRET biosensor
for kinase activity. b Time-lapse FRET/miRFP670nano ratio images of HeLa cell expressing NIR PKA biosensor stimulated with 1 mM dbcAMP and
visualized using pseudocolor. c FRET/miRFP670nano ratio time courses of HeLa cells expressing PKA biosensor stimulated with dbcAMP in the presence
(red) and absence (black) of chemical PKA inhibitor, AT13148 (n= 3 independent experiments). d Time-lapse FRET/miRFP670nano ratio images of HeLa
cell expressing NIR JNK biosensor stimulated with 1 μg ml−1 anisomycin and visualized using pseudocolor. e FRET/miRFP670nano ratio time courses of
HeLa cells expressing JNK biosensor stimulated with anisomycin in the presence (red) and absence (black) of chemical JNK inhibitor, SP600125 (n= 3
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miRFP670nano-miRFP720-based biosensors and the respective
blue-light-activatable kinase regulators (Fig. 7) demonstrated the
wide applicability of miRFP670nano and miRFP670nano-
miRFP720 FRET pair in non-invasive all-optical assays in single
cells and in vivo.
NIR ﬂuorescence makes miRFP670nano a useful probe not
only for crosstalk-free spectral multiplexing in microscopy but
also for deep-tissue imaging. In mice, miRFP670nano performed
similarly to miRFP670 and could be used in multicolor tissue
labeling with red-shifted NIR FP (Fig. 8).
To date, the large number of CBCRs has been cloned. Unlike
natural BphPs, different subclasses of CBCRs exhibit the
remarkable spectral diversity, sensing light from UV to NIR
spectral ranges1. The CBCR spectral tuning is mainly associated
with the characteristic amino acid motifs38, frequently containing
Cys residues able to form thioether bonds with different carbon
atoms of the PCB chromophore, hence affecting the degree of its
electron conjugation. Directed mutagenesis allows changing of
CBCR absorbing spectra; for example, a red/green NpR6012g4
GAF domain was converted to a blue/green variant with three
amino acid substitutions only39. We hypothesize that CBCRs can
be used as a source of the whole new class of small and stable BV-
binding FPs with spectral variety from UV to NIR. The structure
and protein engineering strategy described in this work for
NpR3784-derived NIR FP miRFP670nano should open the door
to future BV-binding FPs with new photophysical and bio-
chemical properties.
Methods
Mutagenesis and directed molecular evolution. The CBCR GAF genes were
synthesized by GenScript Company. The DNA sequences were optimized with
OptimumGene algorithm (GenSript), taking into account the codon usage bias
(human cells), GC (guanine-cytosine) content, CpG dinucleotides content, mes-
senger RNA secondary structure, and other parameters. For expression in bacteria,
DNA sequences encoding the GAF domains were cloned into pBAD/His-B vector
(Life Technologies/Invitrogen) by KpnI/EcoRI sites. BV synthesis in bacteria was
facilitated by co-transformation with a pWA23h plasmid encoding heme oxyge-
nase from Bradyrhizobium ORS278 (hmuO) under the rhamnose promoter17,40.
LMG194 host cells (Invitrogen) were used for protein expression.
All oligonucleotide primers for polymerase chain reaction (PCR) were
purchased from Biomers (Supplementary Table 1). For simultaneous site-speciﬁc
mutagenesis at several positions, an overlap-extension approach was applied.
Random mutagenesis was performed with GeneMorph II random mutagenesis kit
(Agilent Technologies) under conditions resulting in a mutation frequency of up to
16 mutations per 1000 base pairs. After mutagenesis, a mixture of mutated genes
was electroporated into LMG194 host cells containing the pWA23h plasmid.
Typical mutant libraries consisted of more than 108 independent clones. Bacterial
cells were incubated overnight at 37 °C in LB medium supplemented with
ampicillin and kanamycin.
To start protein expression 0.02% rhamnose and 0.004% arabinose were added.
Cells were grown for 5 h at 37 °C, and then at 22 °C for 20 h. Before sorting,
bacterial cells were washed with phosphate-buffered saline (PBS) and diluted with
PBS to an optical density of 0.03 at 600 nm. Flow cytometry screening was
performed on BD Inﬂux cell sorter (BD Biosciences). Six hundred and forty
nanometer laser for excitation and a 670/30 nm emission ﬁlter were used for
selection of positive clones. Collected cells were rescued in SOC medium for 1 h at
37 °C, and then plated on LB/ampicillin/kanamycin Petri dishes supplemented with
0.004% arabinose and 0.02% rhamnose. Leica M205 FA ﬂuorescence
stereomicroscope equipped with a ﬁlter set ET CY5.5 (650/45 nm excitation and
710/50 nm emission ﬁlters) and a CCD camera (Tucsen) was used for screening of
brightest clones. About 30 mutants selected in bacteria were then tested in HeLa
cells, transfected with plasmids obtained after cloning of FP genes into pcDNA3.1
(+) plasmid (Invitrogen/Thermo Fisher Scientiﬁc). A mixture of several selected
mutants was then used as a template for the next round of mutagenesis.
Protein expression and characterization. LMG194 bacterial cells, containing
pWA23h plasmid encoding HO and pBAD/His-B plasmid encoding miRFP670-
nano with polyhistidine tag on the N termini were grown in LB medium supple-
mented with ampicillin and kanamycin. To induce HO expression 0.02% rhamnose
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Fig. 6 HeLa cell stably expressing NIR JNK biosensor co-transfected with p38 kinase translocation reporter (p38 KTR). a p38 KTR-EGFP translocation (top
row) and FRET/miRFP670nano ratio changes (bottom row) upon stimulation with 1 μg ml−1 anisomycin. Dashed line marks the region used for proﬁle
plotting. FRET/miRFP670nano ratio images are visualized using intensity pseudocolor. Scale bar, 10 µm. b Intensity proﬁles of p38 KTR-EGFP ﬂuorescence
before and after stimulation with anisomycin. c Kinetics of FRET/miRFP670nano ratio upon stimulation with anisomycin. The miRFP670nano and FRET
ﬂuorescence signals were detected at 667 and 725 nm, respectively
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was added. After incubation for 3 h at 37 °C, the expression of miRFP670nano was
induced by 0.002% arabinose. Cells were cultured for 3 h at 37 °C and then at 22 °C
for 20 h. For protein puriﬁcation Ni-NTA agarose (Qiagen) was used. Protein was
eluted with PBS containing 100 mM EDTA. For samples desalting PD-10 columns
(GE Healthcare) were used.
Size-exclusion liquid chromatography of puriﬁed miRFP670nano was
performed using HiLoad 16/600 Superdex 200 column (GE Healthcare) at a ﬂow
rate of 1 ml min−1. The column was equilibrated with 10 mM HEPES buffer, pH
7.4, containing 150 mM NaCl, 10% glycerol, 50 μM EDTA, 1 mM dithiothreitol,
0.2 mM phenylmethylsulfonyl ﬂuoride, 0.01% EP-40, and 0.2 mM benzodiazepin.
The column was calibrated with Bio-Rad gel ﬁltration standards.
The ﬂuorescence spectra were recorded with Cary Eclipse Fluorescence
Spectrophotometer (Agilent Technologies), absorbance measurements were
performed with Hitachi U-2000 spectrophotometer. The extinction
coefﬁcient of miRFP670nano was determined as a ratio between the
absorbance value of the peak at Q-band and the value of the peak at Soret
band, given a Soret band extinction coefﬁcient of 39,900 M−1 cm−116. The
ﬂuorescence quantum yield of miRFP670nano was determined using a Nile
blue dye as a standard. pH stability was studied using a series of Hydrion
buffers (Micro Essential Laboratory).
Maturation rate of FPs was compared in LMG194 bacterial cells
expressing miRFP670nano or miRFP670, respectively. Cells were cultured in
LB medium supplemented with ampicillin, kanamycin, and 0.2% rhamnose
for 2 h at 37 °C. Then, protein expression was induced by 0.002% arabinose,
and cells were incubated for 1 h at 37 °C. Next, cells were washed and
resuspended in LB medium supplemented with ampicillin, kanamycin, and
0.2% rhamnose, but without arabinose. Cells were cultured at 37 °C for 8 h.
Fluorescence intensity of the cell suspension was measured every 1 h. To
normalize number of cells, aliquots of the cell suspension were diluted to the
same optical density.
Protein crystallization and structure determination. For crystallization the
protein was dialyzed against 20 mM Tris-HCl, 200 mM NaCl at pH 8.0 buffer and
concentrated to 28.4 mgml−1. Crystallization conditions were found with Mos-
quito crystallization robot (TTP LabTech) using Hampton Research crystallization
and additive screens. Crystals suitable for X-ray data collection were obtained
by hanging drop method from 0.1M sodium acetate at pH 4.0, 10 mM EDTA,
10% v/v isopropanol, and 22% w/v polyethylene glycol 6000. In large-scale
crystallization experiment, 2 μl of the protein solution was mixed with 2 μl of the
reservoir solution and incubated over 500 ml of the same reservoir solution at 20 °C
for 2 weeks.
X-ray data were collected on SER-CAT 22-ID beamline (Advanced Photon
Source, Argonne National Laboratory, Argonne, IL, USA) using standard
equipment of the station. To minimize radiation damage the crystals were ﬂash
frozen in a 100 K nitrogen stream and a helical data collection technique was used
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for all X-ray data acquisitions. Diffraction images were processed with the
HKL200041. The statistics are given in Supplementary Table 2.
The structure of miRFP670nano was solved by the molecular replacement
method with MOLREP42 using the structure of AnPixJ(PDB ID: 3W2Z24) in its
red-absorbing state as a search model. To increase the contrast of rotation function
the search model was truncated to the residues 36–183. To remove model bias, the
chains were rebuilt with the PHENIX.AUTOBUILD crystallographic molecular
model building suite43,44. Real space model correction was performed with
COOT45, structure reﬁnement was done with REFMAC46, and structure validation
was carried out with COOT and PROCHECK47. The reﬁnement statistics is given
in Supplementary Table 3.
Design of mammalian plasmids. To construct mammalian expression plasmids,
the respective genes of miRFP670nano or mutants were inserted in a pcDNA3.1
plasmid (Invitrogen/Thermo Fisher Scientiﬁc) by KpnI/EcoRI sites.
For protein tagging and labeling of intracellular structures study,
miRFP670nano was ampliﬁed, digested with restriction enzymes, and then
swapped with miRFP703 either as C- (for α-tubulin and clathrin) or N-terminal
fusions (for keratin, α-actinin, LifeAct, EB3, myosin, vimentin, clathrin, LAMP1,
and H2B)3.
To engineer caspase-3 activity NIR-reporter, fusion of miRFPP670nano and
miRFP720, containing 11 amino acid linker with the caspase-3 recognition site
(GGDEVDGPVAT), was designed. For this, a miRFP670nano gene was PCR
ampliﬁed using primers containing the linker sequence, NheI and AgeI sites and
inserted into pcDNA3.1 plasmid (Invitrogen/Thermo Fisher Scientiﬁc), then
miRFP720 gene was inserted by AgeI and NotI sites.
To create a JNK and PKA activity NIR-biosensor plasmids, we used a
pJNKAREV-NES (3555NES) and pAKAR3EV-NES (3536NES) plasmids29 kindly
provided by K. Aoki. A YPet gene was replaced with miRFP670nano gene by EcoRI/
XhoI sites. An ECFP gene was replased with miRFP720 gene by NotI/XbaI sites. Then,
fragments encoding NIR sensors were cut out with EcoRI and SalI restriction
endonucleases and inserted into pcDNA3.1 plasmid (Invitrogen/Thermo Fisher
Scientiﬁc). Fragment encoding p38m-KTR was cut out from pLentiPGK Puro DEST
p38KTRClover (a gift from Markus Covert (Addgene plasmid # 59152)) with EcoRI
and AgeI restriction endonucleases and inserted into pEGFP-N1 (Clontech). Venus-
PA-PKI was a gift from Klaus Hahn (Addgene plasmid # 65456). OptoJNKi was cut
out from OptopKCAG-mCherry-OptoJNKi (a gift from Michael Courtney (Addgene
plasmid # 89738)) with EcoRI and BamHI restriction endonucleases and inserted into
pEGFP-C1 (Clontech).
Mammalian cells and transfection. HeLa (CCL-2), U87 (HTB-14), U-2 OS
(HTB-96), and NIH3T3 (CRL-1658) cells were obtained from the ATCC, PC6-3
cells were a kind gift of Dan Lindholm (University of Helsinki). Cells were grown
in a Dulbecco's modiﬁed Eagle's medium (DMEM) medium supplemented with
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10% fetal bovine serum, 0.5% penicillin–streptomycin, and 2 mM glutamine (Life
Technologies/Invitrogen). For microscopy, cells were cultured in 35 mm glass-
bottom Petri dishes (Greiner Bio-One International).
Plasmid transfections were performed using polyethylenimine48. Stably
expressing cells were selected with 1 mgml−1 G418 antibiotic. Sorting of positive
cells was performed using a BD Inﬂux cell sorter (BD Biosciences) equipped with
640 nm laser for excitation and a 670/30 nm emission ﬁlter.
Cell ﬁxation. HeLa cells transfected with miRFP670nano, miRFP670, and
miRFP703 were dissociated from culture dishes with 0.25% trypsin (Gibco/Thermo
Fisher Scientiﬁc), washed and re-suspended in PBS. For ﬁxation, 106 cells were
incubated on ice with 1 ml of 4% paraformaldehyde solution for 10, 30, or 60 min
and then washed. Fluorescence was measured using Cary Eclipse Fluorescence
Spectrophotometer (Agilent Technologies).
Neuronal culture and transfection. Primary rat cortical neurons were prepared in
Neuronal Cell Culture Unit, University of Helsinki. All animal work was performed
in accordance with the ethical guidelines of the European convention and reg-
ulations of an Ethics committee for animal research of the University of Helsinki.
Cells were plated at a density of 600,000–700,000 per glass bottom 35 mm dishes
coated with poly-L-Lysine (0.01 mg ml−1) (Merck) in a neurobasal medium
(Gibco) supplemented with B27 (Life Technologies/Invitrogen), L-glutamine
(Invitrogen), and penicillin-streptomycin (Lonza). Cultured neurons were trans-
fected at 2–3 days in vitro (DIV) with a pcDNA3.1 plasmid (Invitrogen/Thermo
Fisher Scientiﬁc), encoding miRFP670nano using Effectene Transfection Reagent
(Qiagen). Neurons were imaged 48 h after transfection.
Wideﬁeld ﬂuorescence microscopy. Live cells were imaged with an Olympus
IX81 inverted epiﬂuorescence microscope 48 h after the transfection. The micro-
scope was equipped with a 200W metal halide arc lamp (Lumen220PRO, Prior), a
60 × 1.35 numerical aperture (NA) oil objective lens (UPlanSApo, Olympus) and
an opiMOS sCMOS camera (QImaging). During imaging HeLa cells were incu-
bated in a cell imaging medium (Life Technologies-Invitrogen) and kept at 37 °C.
The microscope was operated with a SlideBook v.6.0.8 software (Intelligent Ima-
ging Innovations). To separately image miRFP670nano and miRFP720 in one cell
(two NIR color imaging), the two ﬁlter sets (605/30 nm exciter and 667/30 nm
emitter, and 685/20 nm exciter and 725/40 nm emitter) (Chroma) were used.
Photobleaching measurements of cytoplasmically expressed NIR FPs in live
HeLa cells were performed with the 60 × 1.35 NA oil immersion objective lens
(UPlanSApo, Olympus) and a 650/13 nm (exciter) and 684/24 nm (emitter) ﬁlter
set (Semrock).
To obtain FRET images a 605/30 excitation ﬁlter and two emission ﬁlters (667/
30 nm for miRFP670nano and 725/40 nm for miRFP720) were used. Emission
ratios were obtained by calculating background-subtracted FRET intensities
divided by background-subtracted miRFP670nano intensities for JNK and PKA
NIR biosensors. For caspase-3 reporter FRET to donor intensities ratio was
calculated. FRET measurements were quantiﬁed using ImageJ (NIH). Intensity-
modulated display mode was generated with a full-spectrum lookup table. Time-
course ratio measurements were normalized to baseline prestimulation values.
HeLa cells expressing JNK and PKA NIR biosensors were starved for 6 h with
DMEM medium (Gibco/Thermo Fisher Scientiﬁc) before imaging.
To photoactivate PA-PKI and OptoJNKi, the transfected cells were
continuously illuminated using 460/20 nm custom‐assembled LED array (LED
Engin) at the light power density of 0.5 mW cm−2.
Flow cytometry. The samples were analyzed using a BD Accuri C6 ﬂow cytometer.
Prior to acquisition, cell pellets were washed with PBS and diluted in cold PBS to a
density of 500,000 cells ml−1. At least 50,000 cells per sample were recorded.
miRFP670nano, miRFP670, and miRFP703 were excited with a 640 nm laser and
their ﬂuorescence was detected with a 675/25 or 670 nm LP emission ﬁlters. EGFP
was excited with a 488 nm laser, and its ﬂuorescence was detected with a 510/15 nm
emission ﬁlter. Mean NIR ﬂuorescent intensity of the double-positive cell popu-
lation was normalized to mean green ﬂuorescence intensity of the co-expressed
EGFP to account for transfection efﬁciency. The data were analyzed using a FlowJo
v.7.6.2 software.
Imaging in mice. The Swiss Webster 2- to 3-month-old female mice (National
Cancer Institute, NIH) with body weights of 22–25 g were used. To compare
brightness of miRFP670nano with miRFP670 as well as to show possibility of two-
color imaging HeLa cells were injected subcutaneously in the interscapular area of
FVB mice. For better imaging, the fur on the bellies of the mice was removed using
a depilatory cream. HeLa cells were co-transfected with the pcDNA-
miRFP670nano or pcDNA-miRFP670 and pRluc8 plasmids in a 10:1 ratio for
comparison study. HeLa cells were transfected with the pcDNA-miRFP670nano or
pmiRFP720 and pRluc8 plasmids for two-color study. Various number of HeLa
cells in 100 μl of RPMI-1640 media supplemented with 2 mM L-glutamine were
injected subcutaneously 72 h after the transfection. For ﬂuorescence and biolu-
minescence detection, 1 h after the HeLa cells injection the animals were imaged
using an IVIS Spectrum instrument (Perkin Elmer/Caliper Life Sciences).
Fluorescence was detected with 640/20 nm excitation and 680/30 nm emission
ﬁlters for miRFP670nano or 675/20 nm excitation and 720/30 nm emission ﬁlters
for miRFP720. Bioluminescence was detected with an open emission ﬁlter.
Throughout the imaging, animals were maintained under anesthesia with 1.5%
vaporized isoﬂuorane. Prior to imaging, 80 μg of Inject-A-Lume coelenterazine
substrate for Rluc8 (NanoLight Technology) was intravenously injected through a
retro-orbital vein. Data were analyzed using Living Image 3.0 software (Perkin
Elmer/Caliper Life Sciences).
All animal experiments were performed in an AAALAC-approved facility using
protocols approved by the Albert Einstein College of Medicine Animal Usage
Committee. Forty-ﬁve mice were used in this study.
Reproducibility. The experiments were not randomized. The investigators were
not blinded to allocation during the experiments and outcome assessment. No
sample-size estimation was performed to ensure adequate power to detect a pre-
speciﬁed effect size.
Data availability
The main data supporting the ﬁndings of this study are available within the Article
and its Supplementary materials. The additional data are available from the cor-
responding author on reasonable request. miRFP670nano nucleotide sequence in
GenBank is MK176509. miRFP670nano crystal structure in Protein Data Bank is
6MGH.
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